YY1-低氧轴对血管正常化和改善免疫治疗的临床潜力
Concetta Meo1, Filomena de Nigris1
1Department of Precision Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Cancers
|February 10, 2024
概括
异常的瘤血管系统损害了癌症免疫疗法. 向YY1-HIF通路并采用CAR-T细胞等策略可能会使瘤血管正常化并提高治疗效率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 瘤血管系统异常导致输液不良,缺氧和免疫逃避,对免疫疗法反应产生负面影响.
- 瘤血管生成和免疫抑制是密切相关的,塑造瘤微环境.
- 缺氧瘤微环境触发复杂的血管化和免疫抑制机制.
研究的目的:
- 审查瘤血管生成和免疫调节之间的相互作用.
- 检查YY1-HIF轴在调节瘤血管和免疫微环境中的作用.
- 讨论将瘤血管正常化和增强癌症治疗的策略.
主要方法:
- 关于瘤血管生成,免疫调节和YY1-HIF轴的文献综述.
- 对驱动瘤血管和免疫抑制机制的分析.
- 探索针对瘤血管化的治疗策略.
主要成果:
- YY1-HIF轴在调节瘤血管和免疫微环境方面发挥着至关重要的作用.
- 抗血管原剂和免疫治疗的联合治疗显示出有希望的结果,但需要进一步评估.
- 像准YY1,纳米载体和CAR-T细胞这样的策略有可能使瘤血管正常化.
结论:
- 了解YY1-HIF轴是调节瘤微环境的关键.
- 正常化瘤血管结构对于提高免疫疗法疗效至关重要.
- 针对血管正常化和免疫调节,为增强癌症治疗提供了一个有希望的途径.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K